21st Annual PepTalk Conference: The Protein and Science Production Week
January 18, 2022 at 5:00 PM PST
Dr. Parren will present preclinical data on LAVA’s lead solid tumor Gammabody™ LAVA-1207 as well as new non-human primate data supporting the safety and tolerability profile of LAVA’s lead solid tumor Gammabody™ programs.
Presenter: Paul W.H.I. Parren, Ph.D., Executive Vice President, Head of Research and Development
Presentation Title: Bispecific Gamma-Delta T Cell Engagers Targeting PSMA for the Treatment of Prostate Cancer
Location: San Diego and virtual – Sapphire Session Room